GSK and Pfizer's RSV vaccines to carry warnings of neurological disorder risk
GSK and Pfizer's respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing ...
U.S. Steel Stock Up After Filing Lawsuit With Nippon, Challenging Biden’s Decision.
The lawsuits call President Biden’s decision to block the buyout of the American steel maker by Nippon Steel an ‘unlawful political influence.’ ...
CVS Health's Aetna Files Lawsuit Against Drugmakers For Alleged Inflated Generic Drug Prices
CVS' Aetna sues drug manufacturers for price-fixing and market allocation scheme. The subsidiary seeks damages and ...
PFE Returns Rights to Hemophilia A Candidate to Partner SGMO
PFE ends deal with SGMO for hemophilia A gene therapy candidate. NVS' gene therapy for SMA meets goal in study.
Zacks.com on MSN5d
Pharma Stock Roundup: PFE Ends Hemophilia Deal With SGMO & More
Novartis’ NVS phase III study showed a positive risk-benefit profile of an investigational gene therapy candidate, intrathecal onasemnogene abeparvovec (OAV101 IT), for treating spinal muscular ...
Party City to close in Springfield as company files for Chapter 11 bankruptcy
The party is over for national chain Party City, which will be shuttering doors on hundreds of stores across the US, ...
BioSpace6d
Sangamo’s Stock Plummets as Pfizer Axes Hemophilia Gene Therapy Pact
Sangamo is on course to run out of money within months and has now lost access to up to $220 million in milestone payments ...